Show simple item record

dc.contributor.author Gunatilake, S.B. en_US
dc.contributor.author Settinayake, S. en_US
dc.date.accessioned 2014-10-29T09:22:29Z
dc.date.available 2014-10-29T09:22:29Z
dc.date.issued 2004 en_US
dc.identifier.citation Practical Neurology. 2004; 4(4): pp.194-203 en_US
dc.identifier.issn 1474-7758 (Print) en_US
dc.identifier.issn 1474-7766 (Electronic) en_US
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/1632
dc.description Indexed in MEDLINE
dc.description.abstract Leprosy is a communicable disease due to chronic infection caused by Mycobacterium leprae, principally affecting the skin and peripheral nerves. It does not affect the spinal cord or brain in man. It is still one of the major health problems of developing countries. Case diagnosis and detection are not always clear or consistent, and reporting in many parts of the world is incomplete or irregular. Indeed, because of the fear, shame and social stigma associated with the disease, leprosy is generally under-reported. However, simplified WHO diagnostic criteria along with community awareness programmes have helped in reducing social stigma and improving case detection. The WHO estimated there were 10–12 million cases in the 1980s. The latest estimate (1994) is 2.4 million cases, a reduction of over three-quarters, mainly due to the widespread use of multidrug therapy in leprosy control (WHO 1994). According to the WHO, 543 662 new cases
dc.publisher BMJ Publishing Group en_US
dc.title Leprosy en_US
dc.type Review en_US
dc.identifier.department Medicine en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account